Intravenous Administration of an Oncolytic Vesicular Stomatitis Virus: Clinical Experience to Date

Time: 9:00 am
day: Day Two

Details:

  • Voyager V1 has been administered intravenously to over 100 cancer patients in clinical trials
  • Compelling evidence of single agent activity after a single infusion will be presented

Speakers: